openPR Logo
Press release

Global Exocrine Pancreatic Insufficiency Market Rising from a Valuation of US$2.85 bn by 2023

Global Exocrine Pancreatic Insufficiency Market Rising from

The vendor landscape of the global market for exocrine pancreatic insufficiency features few companies, mostly concentrated in the North America and Europe regions, and a moderate level of competition, says Transparency Market Research in a recent report. With the massive rise in the prevalence of diabetes, considered one of the key causative factors for exocrine pancreatic insufficiency, companies are focusing their expansion strategies on emerging economies in regions such as Asia Pacific.

Some of the leading companies operating in the global exocrine pancreatic insufficiency market are Nordmark Arzneimittel GmbH & Co. KG, Janssen Pharmaceuticals, Inc., AbbVie, Inc., Digestive Care, Inc., and Allergan plc. Transparency Market Research states that the exocrine pancreatic insufficiency market will exhibit a CAGR of 8.3% from 2015 to 2023, rising from a valuation of US$707.0 mn in 2014 to US$2.85 bn by 2023.

More Sensitive Diagnostic Tools to Challenge Market Dominance of CT Scanning On the basis of diagnostic tests, the market for exocrine pancreatic insufficiency features techniques such as blood tests, magnetic resonance imaging (MRI), endoscopic ultra-sonography (EUS), and CT scanning. Of these, the segment of computerized tomography (CT) scan is presently the most preferred technique and accounted for a dominant share in the revenue of the global market in 2014. Although the segment is expected to retain its dominance over the forecast period in terms of revenue contribution to the global market, it is expected to witness sluggish growth owing to the easy availability of advanced and more sensitive diagnostics techniques such as magnetic resonance imaging (MRI).

Request to View Sample Report @

From a geographical standpoint, the market in North America dominated in terms of revenue contribution to the global exocrine pancreatic insufficiency market in 2014 owing to the large pool of patients. The region is also expected to retain its top spot throughout the forecast period, chiefly owing to the rising prevalence of causative diseases such as cystic fibrosis and chronic pancreatitis.

Rising Rate of Incidence of Causative Conditions to Drive Market The rising rate of incidence of diseases such as chronic pancreatitis, cystic fibrosis, and diabetes are contributing to the rising demand for effective treatment and diagnostic tools for exocrine pancreatic insufficiency globally. According to the Cystic Fibrosis Foundation, nearly 70,000 people are living with cystic fibrosis across the globe, of which nearly 30,000 are in the U.S. alone. In the U.S., nearly 1,000 new cases of the condition are diagnosed every year, heightening the risk of exocrine pancreatic insufficiency.

The prevalence of exocrine pancreatic insufficiency is also rising owing to the rising number of diabetics across the globe. Diabetics are at a risk of developing normal inflammations and damage to the pancreatic tissue, signifying a potentially massive risk of emergence of a massive number of new cases of exocrine pancreatic insufficiency in the next few years as diabetes has become highly prevalent globally. The rising population of diabetics worldwide could emerge as one of the key driving factors of the global exocrine pancreatic insufficiency market in the next few years. The factor could be of more prominence in developing economies, especially across Asia Pacific, which presently have the world’s largest pool of diabetics and the numbers are constantly rising.

Read Report Overview @

Stringent Approval Regulations Hinder Growth Prospects While stringent approval regulations of bodies such as the U.S. FDA could hamper the overall growth of the global exocrine pancreatic insufficiency to a certain extent, companies could manage to gather sustainable returns by exploiting the vast untapped growth opportunities in regions such as Asia Pacific and Latin America. Focus on the development of effective drug delivery mechanisms could also benefit companies in the exocrine pancreatic insufficiency market as the area of enteral drug delivery still remains untraversed owing to non-approval of any pancreatic enzyme replacement therapy (PERT) using enteral feeding tubes (EFT) by the FDA.

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Transparency Market Research

State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Exocrine Pancreatic Insufficiency Market Rising from a Valuation of US$2.85 bn by 2023 here

News-ID: 845153 • Views: 125

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases

More Releases for Rising

Telemedicine Market - The Rising Number of Stroke
The global telemedicine market is anticipated to demonstrate promising growth in the coming years, according to a report published by Transparency Market Research (TMR). The market is characterized with the presence of a number of small and large players, and features a highly competitive environment. The leading vendors operating in the global telemedicine market are CISCO Systems, Inc., McKesson Corporation, Polycom Corp., and AMD Global Telemedicine. Vendors are expected to
Rehabilitation Equipment Market - Rising Demand Enhancement 2025
Global Rehabilitation Equipment Market: Snapshot The global market for rehabilitation equipment has been growing alongside the need to improve the quality of life of disabled, elderly, or sick persons. Rehabilitation equipment are used by rehab nurses, physiotherapists, and medical experts in rehab centers. Healthcare asylums are also ardent consumers of rehabilitation equipment, thus, propelling demand within the global market for rehabilitation equipment. The government has been offering incentives to the development
Industrial Sugar Market Rising Health Challenges 2025
Global Industrial Sugar Market: Overview The industrial sugar market is dominated by the food and beverage industry, with the pharmaceuticals industry also claiming a notable share. The rising demand for several types of fast food and beverages is thus an influential factor for the global industrial sugar market. Industrial sugar constitutes a major part of the global sugar market and is expected to retain a significant share in the latter
Radiofrequency Ablation Market - Rising Health Trends 2025
Global Radiofrequency Ablation Market: Overview Radiofrequency ablation is an analgesic procedure wherein radiofrequency waves are targeted on particular muscles or muscle groups. The radiofrequency waves create an electric current, which is used to emit heat onto the affected area. This temporarily deadens the nerve cells in the applied area, leading to reduction in pain. The global radiofrequency ablation market has benefited significantly from the rising demand for noninvasive and minimally invasive
Safety Needles Market Rising participation by 2025
Global Safety Needles Market: Overview Demand for products capable of arresting the rising numbers and gravity of needlestick injuries has been the key factor to have helped the global safety needles market expand at a healthy pace in the recent years. Rising participation of manufacturers, healthcare organizations, and government and non-government bodies in activities and programs aimed at raising awareness regarding the safety hazards induced by reusable needles for patients as
Rising Opportunities in India
6 July 2011 SearchLight Ventures - an investment deal-sourcing firm headquartered in the US – launched operations in India, headquartering in the New Delhi area. Several founding partners relocated there to head up the company’s expansion into the Indian market. The mission of SearchLight Ventures is to replace the inefficient and often sparse physical network between investors and investees, reshaping the manner in which the two interact by streamlining the initial contact